Clinical trial
Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese…
NCT00224783 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00224783 |
|---|---|
| Title | Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults |
| Official title | Placebo-controlled Double-blind Controlled Trial of Single Intranasal Inoculation of CAIV-T Liquid Formulation in Healthy Japanese Male Adults |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Japanese Male Adults |
| Intervention type | Biological |
| Interventions | CAIV-T, Placebo |
| Enrollment | 45 |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Sep 23, 2005 |
| Last update posted | Jan 26, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: